Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: Breast Cancer Res Treat. 2016 Jul 18;158(3):523–534. doi: 10.1007/s10549-016-3887-8

Table 1.

Demographics of participants with an abnormal breast cancer screening test enrolled in the Patient Navigation Research Program by study arm N = 4675

Total Navigated Control p value
N = 2241 N = 2434
N (%) N (%) N (%)
Age (mean, SD) n = 4675 48.7 (11.9) 47.1 (12.1) 50.1 (11.5) p = 0.000
Race/ethnicity n = 4675 p = 0.000
 White 1470 (31.4) 749 (33.4) 721 (29.6)
 Black 913 (19.5) 310 (13.8) 603 (24.8)
 Hispanic 2039 (43.6) 1021 (45.6) 1018 (41.8)
 Other 253 (5.4) 161 (7.2) 92 (3.8)
Language n = 4675 p = 0.171
 English 2789 (59.7) 1314 (58.6) 1475 (60.6)
 Other 1886 (40.3) 927 (41.4) 959 (39.4)
Insurance status n = 4648 n = 2227 n = 2421 p = 0.000
 Private 1168 (25.1) 544 (24.4) 624 (25.8)
 Uninsured/other 1637 (35.2) 848 (38.1) 789 (32.6)
 Public 1843 (39.7) 835 (37.5) 1008 (41.6)
Type of screening abnormality n = 4675 p = 0.000
 Abnormal breast exam 1284 (27.5) 809 (36.1) 475 (19.5)
 BI-RADS 0/other 2558 (54.7) 1042 (46.5) 1516 (62.3)
 BI-RADS 3 646 (13.8) 292 (13.0) 354 (14.5)
 BI-RADS 4/5 187 (4.0) 98 (4.4) 89 (3.7)
PNRP Site n = 4675 p = 0.000
A 1712 (36.6) 749 (33.4) 963 (39.6)
B 352 (7.5) 147 (6.6) 205 (8.4)
D 634 (13.6) 312 (13.9) 322 (13.2)
E 475 (10.2) 282 (12.6) 193 (7.9)
F 448 (9.6) 251 (11.2) 197 (8.1)
G 1054 (22.6) 500 (22.3) 554 (22.8)